Viatris (VTRS) Asset Utilization Ratio (2020 - 2026)
Viatris (VTRS) posted Asset Utilization Ratio of 0.41 for Q2 2026, up 4.22% on a QoQ basis from 0.39 in Q1 2026, and up 11.68% year-over-year from 0.37 in Q2 2025.
Analysis
Viatris (VTRS) Asset Utilization Ratio (2020 - 2026) Analysis & Trends
Viatris has reported Asset Utilization Ratio for 7 years, with the latest figure at 0.41 in Q2 2026.
- On a quarterly basis, Asset Utilization Ratio rose 11.68% year-over-year to 0.41 in Q2 2026; TTM through Jun 2026 was 0.41, a 11.68% increase from a year earlier, with the FY2025 full-year figure at 0.36, up 9.95% from the prior year.
- Asset Utilization Ratio was 0.41 for Q2 2026 at Viatris, up from 0.39 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.41 in Q2 2026, with the low at 0.32 in Q3 2023.
- Average Asset Utilization Ratio over 5 years is 0.34, with a median of 0.33 recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio soared 143.85% in 2022, then fell 5.32% in 2023.
- Over 5 years, Asset Utilization Ratio stood at 0.33 in 2022, then fell by 2.92% to 0.32 in 2023, then increased by 6.81% to 0.34 in 2024, then increased by 11.41% to 0.38 in 2025, then increased by 7.7% to 0.41 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.41 (Q2 2026), 0.39 (Q1 2026), and 0.38 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 0.43 |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 0.41 |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 0.59 |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 0.85 |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 0.44 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 0.23 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 0.67 |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 0.43 |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 0.73 |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.41 |
| Mar 31, 2026 | 0.39 |
| Dec 31, 2025 | 0.38 |
| Sep 30, 2025 | 0.37 |
| Jun 30, 2025 | 0.37 |
| Mar 31, 2025 | 0.36 |
| Dec 31, 2024 | 0.34 |
| Sep 30, 2024 | 0.33 |
| Jun 30, 2024 | 0.33 |
| Mar 31, 2024 | 0.32 |
| Dec 31, 2023 | 0.32 |
| Sep 30, 2023 | 0.32 |
| Jun 30, 2023 | 0.32 |
| Mar 31, 2023 | 0.32 |
| Dec 31, 2022 | 0.33 |
| Sep 30, 2022 | 0.34 |
| Jun 30, 2022 | 0.33 |
| Mar 31, 2022 | 0.33 |
| Dec 31, 2021 | 0.32 |
| Sep 30, 2021 | 0.30 |